Krka, d. d. (WSE:KRK)

Market Cap	22.77B
Revenue (ttm)	8.17B
Net Income (ttm)	1.53B
Shares Out	n/a
EPS (ttm)	49.62
PE Ratio	14.90
Forward PE	n/a
Dividend	32.10 (4.32%)
Ex-Dividend Date	Jul 23, 2024

Volume	2
Average Volume	132
Open	750.00
Previous Close	744.00
Day's Range	750.00 - 750.00
52-Week Range	534.00 - 776.00
Beta	0.50
RSI	59.88
Earnings Date	Apr 10, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, infections, oncology, and other diseases. It provides non-prescription products for oral cavity and pharynx; cough and cold;...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 11,308
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: KRK

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.

Financial numbers in EUR